![]() |
3/1998 |
Quantitative Measurement Regarding the Tissue Storage of Middle Molecular Hydroxyethyl Starch 200/0,5 in Patients with Multiple Organ Failure P. Lukasewitz, U. Kroh, O. Löwenstein, M. Krämer, H. Lennartz Objective: Quantitative
determination of the concentration of hydroxyethyl starch
(HES) in different organs (liver, kidney, lung, spleen,
pancreas, lymphnodes and small intestine) in 12 deceased
patients of ICU. Patients and methods: Primarily the
patients had been treated because of respiratory
insufficiency (ARDS) of various causes. Persistent sepsis
and multi organ failure resulted in their death. All of
them had been continuously veno-venous haemofiltrated
(CVVH) over a longer period because of acute renal
failure. The patients received an average of 9,42 l ±
3,85 l HES 200/0,5 (942 ± 385 g hydroxyethyl starch)
during the time of 41 ± 22 days. Analysis has been
performed in a modified chemical method to measure
glycogen. Results: We found the highest quantities of HES
concentration in all patients in the kidneys (up to 26,4
mg/g), the lowest quantities we determined in the
pancreas and small intestine. All in all only about 3% -
4% of the infused amount of HES could be detected in the
investigated organs. Conclusions: The accumulated mass of
HES in the organs is very low. From our investigations we
conclude, that intracellular cleavage of HES molecules in
patients with renal failure is more relevant than
intravasale hydrolysis. Key words:
Hydroxyethyl starch, tissue storage, multiple organ
failure Dr. P. Lukasewitz |
| PABST SCIENCE
PUBLISHERS Lengerich, Berlin, Düsseldorf, Leipzig, Riga, Scottsdale AZ (USA), Wien, Zagreb |